Aeris Capital AG is a private equity fund and financial advisor with locations in the United States and Switzerland.
Business Model:
Revenue: $24.3M
Employees: 201-500
Address: Churerstrasse 70
City: Pfäffikon
State: zurich
Zip: 8808
Country: CH
[Aeris Capital](http://www.aeris-capital.com/) AG is a private equity fund and financial advisor with locations in the United States and Switzerland.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2012 | Nanosolar | Private Equity Round | 70M |
10/2015 | Affimed | Post-IPO Equity | 0 |
1/2011 | Smaato | Series C | 7M |
8/2009 | ConforMIS | Series D | 50M |
9/2014 | Affimed | Series E | 0 |
10/2009 | Adamas Pharmaceuticals | Series D | 40M |
3/2008 | mobileo | Seed Round | 3.8M |
11/2014 | Butterfly Network | Venture Round | 0 |
5/2010 | Coda Automotive | Series C | 58M |
4/2010 | Affimed | Series C | 0 |
9/2014 | Jiff | Series B | 0 |
1/2014 | Sonetik | Series A | - |
6/2016 | Jiff | Series C | 0 |
5/2015 | Jiff | Series C | 0 |
1/2011 | Coda Automotive | Series D | 0 |
2/2010 | Mode Media | Series E | 0 |
1/2008 | Smaato | Series A | 3.6M |
2/2013 | Atlantium | Venture Round | 9M |
9/2013 | GenomeDx Biosciences | Series B | - |
7/2008 | ConforMIS | Series D | 14.9M |
1/2012 | GenomeDx Biosciences | Series A | - |
11/2014 | Curetis | Series B | 0 |
1/2013 | Crescendo Bioscience | Series D | 28M |
12/2009 | Curetis | Series A | 27.9M |
3/2012 | Jiff | Series A | 7.5M |
10/2012 | Affimed | Series D | 20.1M |
12/2013 | Invincea | Series C | 16M |
6/2017 | GenomeDx Biosciences | Venture Round | 6.3M |
6/2011 | Smaato | Series D | 3M |
12/2009 | Smaato | Series B | 4.5M |
8/2014 | Smaato | Series E | 25M |
12/2015 | Solstice Biologics | Series A | 4M |
12/2012 | Solstice Biologics | Private Equity Round | 7.5M |
9/2011 | Crescendo Bioscience | Series C | 56M |
11/2009 | Tethys BioScience | Series D | 25M |
7/2011 | SynapSense | Series C | 16M |
9/2010 | Livescribe | Series C | 44.8M |
1/2013 | Solstice Biologics | Series A | 18M |
6/2017 | GenomeDx Biosciences | Venture Round | 0 |
6/2016 | Jiff | Series C | 0 |
12/2015 | Solstice Biologics | Series C | 0 |
10/2015 | Affimed | Post-IPO Equity | 0 |
5/2015 | Jiff | Series C | 0 |
11/2014 | Curetis | Series B | 0 |
11/2014 | Butterfly Network | Venture Round | 0 |
9/2014 | Jiff | Series B | 0 |
9/2014 | Affimed | Series E | 0 |
8/2014 | Smaato | Series E | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|